TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.10
+0.01 (+0.48%)
Open$2.07
Previous Close$2.09
Day High$2.10
Day Low$2.06
52W High$2.95
52W Low$0.99
Volume—
Avg Volume15.9K
Market Cap24.07M
P/E Ratio134.50
EPS$0.02
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+465.7% upside
Current
$2.10
$2.10
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.99M | 8.53M | 4.86M |
| Net Income | -564,035 | -1,446,655 | 1.27M |
| Profit Margin | -18.8% | -17.9% | 26.2% |
| EBITDA | -3,970,028 | -10,748,152 | 2.17M |
| Free Cash Flow | — | — | 1.08M |
| Rev Growth | -64.9% | -64.9% | +8.5% |
| Debt/Equity | — | — | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |